CDH1 and breast carcinoma: EMP-specific cellular phenotypes can be isolated using EpCAM, Integrin-β4 or CD44/CD24 expression in basal-like cell lines representing TNBC [26,27,28,29], or by using E-cadherin in mammary carcinoma in mouse PyMT models [30].